Literature DB >> 15182227

Induction of cellular oxidative stress by the beta-amyloid peptide involved in Alzheimer's disease.

Gillian L Gibson1, David Allsop, Brian M Austen.   

Abstract

Beta-amyloid, the 39-43 amino acid peptide fragment originating from amyloid precursor protein, is today, generally accepted as the biological entity responsible for causing the debilitating human disorder Alzheimer's disease. Understanding the exact biological effects of beta-amyloid in vitro and in vivo is clearly important to provide therapeutic strategies for the disease. Recent in vitro studies have focused on the production of reactive oxygen species by aggregating beta-amyloid, but the cellular effects of beta-amyloid induced reactive oxygen species production have not been fully elucidated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15182227     DOI: 10.2174/0929866043407101

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN: 0929-8665            Impact factor:   1.890


  3 in total

Review 1.  Alzheimer's disease hypothesis and related therapies.

Authors:  Xiaoguang Du; Xinyi Wang; Meiyu Geng
Journal:  Transl Neurodegener       Date:  2018-01-30       Impact factor: 8.014

Review 2.  Silymarin's Inhibition and Treatment Effects for Alzheimer's Disease.

Authors:  Hong Guo; Hui Cao; Xiaowei Cui; Wenxiu Zheng; Shanshan Wang; Jiyang Yu; Zhi Chen
Journal:  Molecules       Date:  2019-05-06       Impact factor: 4.411

Review 3.  Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer's disease: Current trends and future perspectives.

Authors:  Livia La Barbera; Emanuele Mauri; Marcello D'Amelio; Manuele Gori
Journal:  Front Neurosci       Date:  2022-08-04       Impact factor: 5.152

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.